WallStSmart
CLLS

Cellectis SA

NASDAQ: CLLS · HEALTHCARE · BIOTECHNOLOGY

$3.90
+4.56% today

Updated 2026-04-30

Market cap
$391.30M
P/E ratio
P/S ratio
4.92x
EPS (TTM)
$-0.67
Dividend yield
52W range
$1 – $5
Volume
0.0M

Cellectis SA (CLLS) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$53.87M$60.83M$91.34M$69.23M$131.89M$115.11M$44.11M$167.34M$372.88M$330.68M$332.88M$500.84M$467.47M$469.47M$382.08M$261.22M$334.27M$383.54M
Cash & equivalents$36.74M$39.78M$65.33M$31.98M$54.93M$28.84M$10.44M$136.62M$343.56M$290.50M$296.98M$451.89M$360.91M$241.15M$185.64M$89.79M$136.71M$143.25M
Current assets$42.73M$48.14M$74.76M$47.57M$70.63M$51.47M$27.54M$160.51M$365.40M$311.79M$323.22M$487.64M$391.52M$315.36M$225.43M$143.81M$233.01M$287.07M
Total liabilities$10.33M$14.62M$18.12M$19.10M$94.86M$33.42M$37.46M$94.95M$84.67M$56.63M$46.98M$50.57M$112.00M$160.63M$145.60M$135.28M$249.57M$252.51M
Current liabilities$8.18M$12.78M$15.44M$17.02M$26.96M$28.36M$32.20M$91.04M$84.12M$56.04M$43.53M$46.87M$62.60M$52.02M$49.35M$62.99M$155.14M$166.27M
Long-term debt$4.65M$3.42M$2305.00$29447.00$13000.00$1.02M$46.54M$28.84M$18.77M$20.53M$28.44M$43.99M
Shareholder equity$43.54M$46.21M$73.22M$50.13M$37.02M$78.93M$6.95M$73.92M$287.42M$272.18M$266.79M$409.30M$315.12M$283.80M$221.29M$117.97M$84.69M$131.03M
Retained earnings$-10.72M$-67.18M$-28.90M$-84.28M$24320.00$-172.45M$-229.77M$-351.30M$-405.32M$-508.48M$-587.03M$-698.33M$-439.50M$-405.77M$-329.61M
Accounts receivable$4.01M$5.03M$4.78M$12.07M$14.88M$20.19M$15.68M$19.55M$16.55M$12.32M$4.57M$22.07M$15.29M$19.19M$31.07M$17.57M$23.13M$23.04M
Inventory$173502.00$168443.00$169064.00$203484.00$811353.00$935012.00$506780.00$164161.00$172741.00$117790.00$250000.00$275000.00$2.90M$1.61M$0.00$21.77M$1000.00
Goodwill$38.03M$1.51M$0.00$-1000.00$1000.00